Targeting the Host to Create Vaccine-like Cross-Protection Against Emerging Human Coronaviruses
Channel: Benam Lab for Lung Microengineering @ U Pitt
Date: 2021-08-05

This video abstract summarizes the recent study published by Dr. Benam and his team at #NanoSelect on preclinical repurposing of nafamostat mesylate for treatment of coronaviruses in human-derived lung tissue. Read full article here: https://onlinelibrary.wiley.com/doi/10.1002/nano.202100123.